Cumba, Guendelyn .
HRN: 25-55-15 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/20/2024
CEFUROXIME 1.5GM (VIAL)
09/20/2024
09/22/2024
IV
4 Doses 1.5gm
Q8
Post Op
Waiting Final Action
09/20/2024
CEFUROXIME 500MG (TAB)
09/20/2024
09/26/2024
PO
500mg
BID
Post Op
Waiting Final Action
09/20/2024
METRONIDAZOLE 500MG (TAB)
09/20/2024
09/26/2024
PO
500mg
Tid
Postop
Waiting Final Action